SAVR linked to ‘excellent’ long-term survival for patients with bicuspid aortic valves

February 5, 2026 - 20:23

New research provides robust evidence for the long-term effectiveness of surgical aortic valve replacement (SAVR) in patients with bicuspid aortic valve (BAV) disease. A major analysis of nearly 28,000 patients who underwent SAVR reveals high survival rates decades after the procedure.

The study, which represents one of the most comprehensive reviews on the subject, followed patients over an extended period. The data indicates that both men and women with BAV disease, a common congenital heart condition, experience similarly positive outcomes following the open-heart surgery. This challenges some prior assumptions and offers reassurance regarding the durability of SAVR for this specific patient population.

BAV patients often require intervention earlier in life than those with typical three-leaflet valves, making long-term data crucial for surgical decision-making. The findings solidify SAVR's role as a reliable and lasting treatment option, with survival statistics supporting its continued use. The analysis underscores the importance of individualized patient assessment by heart teams to determine the optimal treatment pathway for aortic valve disease.